Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock

NCT ID: NCT05833607

Last Updated: 2023-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-07

Study Completion Date

2024-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The sudy objective is to evaluate the cerebral haemodynamic status in different ranges of systemic arterial pressure in patients with septic shock by noninvasive tools, transcranial doppler and intracranial compliance by mechanical sensor (B4C).

Patients participating in the study will be submitted to different levels of arterial pressure, titrated with vasopressor and them their cerebral hemodynamic variables will be evaluated,

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sepsis is the most prevalent cause of admissions to the intensive care unit (ICU) and many of these patients develop septic shock (SC) (need for vasoactive drug, after adequate fluid administration, plus hyperlactatemia). The SC involvement is systemic, so the investigators started to monitor organ dysfunctions and their perfusion windows, including neurological disorders, when is affected, in addition to indicating severity, are also a predictor of worse prognosis.

The principle of cerebral autoregulation (CA) is the basic defense mechanism against pressure oscillations in the most diverse contexts. The SC is a state of vasodilation and consequent drop in mean arterial pressure (MAP), that under normal physiological conditions would be compensated by CA. But it is not known exactly how CA performance at this profile of patients.

The investigators will assess cerebral hemodynamics in SC patients at different MAP targets, in order to identify whether this regulatory variable would be able to generate better parameters of cerebral hemodynamics.

Some smaller studies have shown that liver and heart dysfunction correlate with worsening autoregulation. Another clinical trial showed an inverse relationship between CA and the Sequential Organ Failure Assessment, in addition to the loss of CA in patients with circulatory shock in general. Post-mortem data found generalized ischemic lesions in the brain of septic patients, which translates into a state of reduction at vascular flow. This patient profile has more blood-brain barrier dysfunction, but further studies are needed to correlate CA and CS.

The study will be carried out in the ICU of Hospital São Rafael (HSR), located in the city of Salvador-Ba, Brazil. For the evaluation of cerebral hemodynamics Transcranial Doppler and a Mechanical sensor (B4C) will be used.

Data collection on admission will include the following: demographic characteristics, comorbidities, source of infection, Sequential Organ Failure Assessment (SOFA) at ICU admission, temperature, Glasgow Coma scale (GCE) or Richmond Agitation Sedation Scale (RASS), mechanical ventilation, arterial blood gasses before and after the protocol.

All patients will be monitored with an arterial line, cardioscopy, pulse oximetry and capnography (if unavailable at the time of collection, this will be described). Before starting the monitoring, the proper functioning of the arterial circuit will be confirmed and a blood gas analysis will be collected, as well as at the end.

The investigators will collet data with the patient's baseline pressure for 5 minutes (T0), then through the titration of vasopressors, for another 5 minutes each mean arterial pressure target at 65mmHg (T1), 75 mmHg (T2) and 85 mmHg (T3). After collection, the baseline mean arterial pressure will be restored

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Septic Shock Cerebral Autoregulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ALL PATIENTS

All patients are monitored with the transcranial Doppler helmet and the 2Hz probe in one of the middle cerebral hemispheres and the Brain 4 care on the other side.

Necessary monitoring: arterial line, electrocardiographic monitor, pulse oximetry, temperature. ETCO2 monitoring whenever possible.

Step 1: Test arterial line circuit, ensure proper temperature, arterial blood gases Step 2: Record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), for 5 min Step 3: Vasopressor titrant for 3 MAP targets (65, 75 and 85 mmHg) , record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), each target record for 3 minutes Step 4: Arterial blood gases, gradually restore PAM to baseline value

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \< 48 hours in the intensive care unit
* Septic shock (sepsis 3.0)

Exclusion Criteria

* No window for DTC
* Hepatic or uremic encephalopathy
* Pregnancy
* Acute or prior structural neurological insult
* Exogenous intoxication
* Dementia
* Chronic Obstructive Pulmonary Disease
* Instability for acute arrhythmia
* Extracorporeal support by modifying the pulse wave form (intra aortic balloon pump and Extracorporeal membrane oxygenation
* Extreme severity, with imminent risk of death
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

D'Or Institute for Research and Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juliana Caldas, Phd

Role: PRINCIPAL_INVESTIGATOR

D'Or Institute for Research and Education (IDOR), Hospital São Rafael

Pedro Cury

Role: STUDY_CHAIR

D'Or Institute for Research and Education (IDOR), Hospital São Rafael

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

São Rafael Hospital

Salvador, Estado de Bahia, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pedro Cury

Role: CONTACT

+5571991950585

Juliana Caldas

Role: CONTACT

+55 71 9901-9500

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Juliana Caldas

Role: primary

+55 71 99901-9500

Pedro Cury

Role: backup

+55 71 991950585

References

Explore related publications, articles, or registry entries linked to this study.

Cury P, Passos RDH, Alves F, Brasil S, Frigieri G, Taccone FS, Panerai RB, Caldas J. Impact of different blood pressure targets on cerebral hemodynamics in septic shock: A prospective pilot study protocol-SEPSIS-BRAIN. PLoS One. 2024 Oct 14;19(10):e0304412. doi: 10.1371/journal.pone.0304412. eCollection 2024.

Reference Type DERIVED
PMID: 39401208 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://pubmed.ncbi.nlm.nih.gov/26903338/

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

https://pubmed.ncbi.nlm.nih.gov/34599691/

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

https://pubmed.ncbi.nlm.nih.gov/34764472/

Cerebral dysfunctions caused by sepsis during ageing

https://pubmed.ncbi.nlm.nih.gov/31764617/

Dynamic Autoregulation is Impaired in Circulatory Shock

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280405/

Impaired cerebral autoregulation is associated with brain dysfunction in patients with sepsis

https://pubmed.ncbi.nlm.nih.gov/35332426/

Waveform Morphology as a Surrogate for ICP Monitoring: A Comparison Between an Invasive and a Noninvasive Method

https://link.springer.com/article/10.1007/s10877-022-00941-y

Noninvasive intracranial pressure waveforms for estimation of intracranial hypertension and outcome prediction in acute brain-injured patients

https://pubmed.ncbi.nlm.nih.gov/23134661/

Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors

https://pubmed.ncbi.nlm.nih.gov/34945774/

A Novel Noninvasive Technique for Intracranial Pressure Waveform Monitoring in Critical Care

https://www.frontiersin.org/articles/10.3389/fneur.2022.958166/full

Daily blood pressure variability in relation to neurological functional outcomes after acute ischemic stroke

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

28134720.1.0000.0048

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.